Travere Therapeutics Inc.

10/26/2024 | Press release | Distributed by Public on 10/26/2024 09:34

Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024